STEMI (ST ELEVATION MI)
Clinical trials for STEMI (ST ELEVATION MI) explained in plain language.
Never miss a new study
Get alerted when new STEMI (ST ELEVATION MI) trials appear
Sign up with your email to follow new studies for STEMI (ST ELEVATION MI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart attack drug shows promise for microvascular damage
Disease control Recruiting nowThis study tests whether the drug ranolazine can protect the tiny blood vessels in the heart after a major heart attack. Researchers will enroll 100 adults who have had a specific type of heart attack (STEMI) and have blockages in multiple arteries. Participants will either recei…
Matched conditions: STEMI (ST ELEVATION MI)
Phase: PHASE2, PHASE3 • Sponsor: Federico II University • Aim: Disease control
Last updated May 26, 2026 05:26 UTC
-
Heart attack patients may ditch aspirin: new trial tests safer drug combo
Disease control Recruiting nowThis study tests whether using only the blood thinner ticagrelor (instead of the usual aspirin plus ticagrelor) can lower bleeding risks in people who had a heart attack but did not get stents or bypass surgery. About 2,570 adults will be followed for 12 months to see if the sing…
Matched conditions: STEMI (ST ELEVATION MI)
Phase: PHASE3 • Sponsor: Montreal Heart Institute • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
Balloon vs. stent: could a temporary fix beat a permanent implant for young heart attack patients?
Disease control Recruiting nowThis study tests whether a drug-coated balloon (DCB) works as well as a drug-eluting stent (DES) in young adults (ages 18–50) having a severe heart attack. The balloon is temporary and leaves nothing behind, which may reduce long-term risks like blood clots and the need for prolo…
Matched conditions: STEMI (ST ELEVATION MI)
Phase: PHASE3 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New drug aims to limit heart damage after attack
Disease control Recruiting nowThis study tests a medicine called Xolatryp in adults who have had a severe type of heart attack (STEMI) and are getting a procedure to open the blocked artery. Participants receive either Xolatryp or a placebo as a one-time IV infusion over 6 hours. The study checks if the drug …
Matched conditions: STEMI (ST ELEVATION MI)
Phase: PHASE2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated May 18, 2026 12:12 UTC